Search PDMR transactions

Notifier
Name of person with notification obligation
Axel Schörling
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Axel Schörling
Position
Deputy CEO/Deputy Managing Director
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
EQL Pharma AB
Issuer’s LEI code
549300Q8B2D2AE8GCW21
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share EQL Pharma (EQL) SE0005497732 Acquisition 4,870 Quantity 30.25 SEK 16/12/2020 SPOTLIGHT STOCK MARKET
Share EQL Pharma (EQL) SE0005497732 Acquisition 2,326 Quantity 32.20 SEK 17/12/2020 SPOTLIGHT STOCK MARKET
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
EQL Pharma (EQL) SE0005497732 Acquisition 16/12/2020 SPOTLIGHT STOCK MARKET 4,870 (Quantity) 30.25 SEK
EQL Pharma (EQL) SE0005497732 Acquisition 17/12/2020 SPOTLIGHT STOCK MARKET 2,326 (Quantity) 32.20 SEK
<< Back